Tocqueville Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.12M | Sell |
90,968
-79,865
| -47% | -$6.44M | 0.09% | 184 |
|
|
2026
Q1 | $14.8M | Sell |
170,833
-37,955
| -18% | -$3.64M | 0.22% | 122 |
|
|
2025
Q4 | $20.1M | Sell |
208,788
-13,725
| -6% | -$1.33M | 0.29% | 92 |
|
|
2025
Q3 | $21.2M | Buy |
222,513
+8,268
| +4% | +$760K | 0.31% | 90 |
|
|
2025
Q2 | $18.7M | Buy |
214,245
+1,648
| +0.8% | +$140K | 0.28% | 104 |
|
|
2025
Q1 | $19.1M | Buy |
212,597
+20,466
| +11% | +$1.83M | 0.31% | 93 |
|
|
2024
Q4 | $15.3M | Buy |
192,131
+180
| +0.1% | +$15.6K | 0.24% | 108 |
|
|
2024
Q3 | $17.3M | Buy |
191,951
+1,313
| +0.7% | +$110K | 0.27% | 99 |
|
|
2024
Q2 | $15M | Buy |
190,638
+1,860
| +1% | +$152K | 0.25% | 105 |
|
|
2024
Q1 | $16.5M | Buy |
188,778
+54,725
| +41% | +$4.67M | 0.27% | 102 |
|
|
2023
Q4 | $11M | Sell |
134,053
-233
| -0.2% | -$17.8K | 0.2% | 120 |
|
|
2023
Q3 | $10.5M | Buy |
134,286
+112,827
| +526% | +$9.45M | 0.2% | 128 |
|
|
2023
Q2 | $1.89M | Sell |
21,459
-32
| -0.1% | -$2.75K | 0.03% | 269 |
|
|
2023
Q1 | $1.73M | Sell |
21,491
-900
| -4% | -$73.4K | 0.03% | 282 |
|
|
2022
Q4 | $1.74M | Buy |
22,391
+3,470
| +18% | +$281K | 0.03% | 297 |
|
|
2022
Q3 | $1.53M | Sell |
18,921
-7,074
| -27% | -$636K | 0.03% | 310 |
|
|
2022
Q2 | $2.33M | Sell |
25,995
-225
| -0.9% | -$22.8K | 0.04% | 297 |
|
|
2022
Q1 | $2.91M | Sell |
26,220
-130
| -0.5% | -$13.7K | 0.04% | 303 |
|
|
2021
Q4 | $2.73M | Buy |
26,350
+109
| +0.4% | +$12.6K | 0.04% | 336 |
|
|
2021
Q3 | $3.29M | Sell |
26,241
-284
| -1% | -$36.8K | 0.05% | 307 |
|
|
2021
Q2 | $3.29M | Sell |
26,525
-825
| -3% | -$104K | 0.05% | 316 |
|
|
2021
Q1 | $3.23M | Buy |
27,350
+1,151
| +4% | +$135K | 0.05% | 313 |
|
|
2020
Q4 | $3.07M | Buy |
26,199
+1,096
| +4% | +$121K | 0.05% | 290 |
|
|
2020
Q3 | $2.61M | Buy |
25,103
+661
| +3% | +$66.4K | 0.05% | 280 |
|
|
2020
Q2 | $2.24M | Buy |
+24,442
| New | +$2.34M | 0.05% | 287 |
|
|
2017
Q3 | – | Sell |
-2,856
| Closed | -$254K | – | 830 |
|
|
2017
Q2 | $254K | Hold |
2,856
| – | – | ﹤0.01% | 693 |
|
|
2017
Q1 | $230K | Hold |
2,856
| – | – | ﹤0.01% | 724 |
|
|
2016
Q4 | $203K | Sell |
2,856
-239
| -8% | -$18.8K | ﹤0.01% | 763 |
|
|
2016
Q3 | $267K | Sell |
3,095
-41
| -1% | -$3.57K | ﹤0.01% | 732 |
|
|
2016
Q2 | $272K | Sell |
3,136
-1,001
| -24% | -$80.9K | ﹤0.01% | 742 |
|
|
2016
Q1 | $310K | Sell |
4,137
-652
| -14% | -$49.1K | ﹤0.01% | 720 |
|
|
2015
Q4 | $368K | Buy |
4,789
+775
| +19% | +$58.3K | 0.01% | 732 |
|
|
2015
Q3 | $269K | Sell |
4,014
-242
| -6% | -$17.8K | ﹤0.01% | 831 |
|
|
2015
Q2 | $315K | Buy |
4,256
+7
| +0.2% | +$535 | ﹤0.01% | 827 |
|
|
2015
Q1 | $331K | Buy |
4,249
+96
| +2% | +$7.28K | ﹤0.01% | 791 |
|
|
2014
Q4 | $300K | Buy |
4,153
+158
| +4% | +$11K | ﹤0.01% | 815 |
|
|
2014
Q3 | $248K | Sell |
3,995
-1,187
| -23% | -$75.5K | ﹤0.01% | 773 |
|
|
2014
Q2 | $330K | Buy |
5,182
+263
| +5% | +$16K | ﹤0.01% | 837 |
|
|
2014
Q1 | $303K | Sell |
4,919
-37,415
| -88% | -$2.18M | ﹤0.01% | 696 |
|
|
2013
Q4 | $2.43M | Buy |
+42,334
| New | +$2.4M | 0.03% | 363 |
|
Other funds holding MDT
Tocqueville Asset Management's MDT Position: Q2 2026 in Review
Tocqueville Asset Management reduced its Medtronic (MDT) stake by 47% in Q2 2026, selling an estimated $6.44M and leaving 90,968 shares worth $7.12M. The position accounts for 0.09% of the portfolio, ranked #184.
Tocqueville Asset Management first reported a position in MDT in Q4 2013 and has held it in 40 quarters since. The position peaked at $21.2M in Q3 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Tocqueville Asset Management held 90,968 shares of Medtronic worth $7.12M as of Q2 2026.
- Tocqueville Asset Management sold 79,865 Medtronic shares in Q2 2026, an estimated $6.44M.
- Medtronic made up 0.09% of Tocqueville Asset Management's portfolio in Q2 2026, its #184 holding.
- Tocqueville Asset Management first reported a position in Medtronic in Q4 2013 and has held it in 40 quarters since.
- Tocqueville Asset Management's Medtronic position peaked at $21.2M in Q3 2025.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Tocqueville Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.